Eli Lilly & Co
LLY· NYSE
Released Feb 22, 2011
10-K filed Feb 22, 2011, -1,773 days after period end · 0001193125-11-041620
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $5.38B | $5.12B | $5.81B | $5.96B |
| Net Income | $478.40M | $428.50M | $727.50M | $827.20M |
| EPS Diluted | $0.45 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $0.40 |
| $0.67 |
| $0.74 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.